Stock listing
TELO Stock Price, News, Filings & Events — Telomir Pharmaceuticals, Inc.
Selected listing: TELO · NASDAQ · USD · US
This page tracks Telomir Pharmaceuticals, Inc.'s TELO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TELO:NASDAQ. TELO:NASDAQ is the stock-level entry point for investors researching Telomir Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Telomir Pharmaceuticals, Inc. (TELO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- TELO:NASDAQ
- Asset type
- Stock
- Market cap
- $80.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Telomir Pharmaceuticals, Inc. TELO:NASDAQ stock context
This page tracks Telomir Pharmaceuticals, Inc.'s TELO:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TELO:NASDAQ. TELO:NASDAQ is the stock-level entry point for investors researching Telomir Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Telomir Pharmaceuticals, Inc. (TELO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Telomir Pharmaceuticals, Inc.
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
August 10, 2026
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensiti...
June 15, 2026
Telomir Pharmaceuticals Reports Peer-Reviewed Publication of Telomir-Zn Data Demonstrating Improved Survival and Multiple Endpoint Benefi...
May 20, 2026
Telomir Pharmaceuticals Announces FDA Clearance of IND for Telomir-Zn in Triple-Negative Breast Cancer
April 30, 2026
Telomir Pharmaceuticals Completes Acquisition of TELI Pharmaceuticals, Securing Global Rights to Telomir-1
April 27, 2026
Research Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for TELO:NASDAQ.
Telomir Pharmaceuticals, Inc. company profile
View the public company page for Telomir Pharmaceuticals, Inc. on 6ix.
Telomir Pharmaceuticals, Inc. news
Read company news and market updates connected to Telomir Pharmaceuticals, Inc..
Telomir Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Telomir Pharmaceuticals, Inc..